Gene transfer of pigment epithelium-derived factor suppresses tumor growth and angiogenesis in a hepatoblastoma xenograft model

Pediatric Research

Volumn 60, Issue 3, 2006, Pages 282-287

  Browne, Marybeth ^a   Stellmach, Veronica ^b   Cornwell, Mona ^b   Chung, Chuhan ^b   Doll, Jennifer A ^b   Lee, Eun Jig ^b   Jameson, J Larry ^b   Reynolds, Marleta ^a   Superina, Riccardo A ^a   Abramson, Lisa P ^a   Crawford, Susan E ^b  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; NEUTRALIZING ANTIBODY; PARVOVIRUS VECTOR; PIGMENT EPITHELIUM DERIVED FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE TRANSFER; HEPATOBLASTOMA; HUMAN; HUMAN CELL; LIVER CELL; LIVER CIRCULATION; MITOSIS; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; EYE PROTEINS; FEMALE; GENE THERAPY; HEPATOBLASTOMA; HUMANS; LIVER NEOPLASMS; MICE; NEOVASCULARIZATION, PATHOLOGIC; NERVE GROWTH FACTORS; SERPINS; TRANSPLANTATION, HETEROLOGOUS;

EID: 33747587631     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.pdr.0000232789.86632.91     Document Type: Article

References (38)

1. Stocker JT, Schmidt D 2000 Hepatoblastoma. In: Hamilton SR, Aaltonen LA (eds) Pathology and Genetics: Tumors of the Digestive System. Lyon Press, Oxford, pp 184-189
2. Sun XY, Wu ZD, Liao XF, Yuan JY 2005 Tumor angiogenesis and its clinical significance in pediatric malignant liver tumors. World J Gastroenterol 11:741-743
3. von Schweinitz D, Fuchs J, Gluer S, Pietsch T 1998 The occurrence of liver growth factor in hepatoblastoma. Eur J Pediatr Surg 8:133-136
4. Kim MS, Lee YM, Moon EJ, Kim SE, Lee JJ, Kim KW 2000 Anti-angiogenic activity of torilin, a sesquiterpene compound isolate from Torilis japonica. Int J Cancer 87:269-275
5. Kim KR, Moon HE, Kim KW 2002 Hypoxia-induced angiogenesis in human hepatocellular carcinoma. J Mol Med 80:703-714
6. Shweiki D, Itin A, Soffer D, Keshet E 1992 Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845
7. Plate KH, Breier G, Weich HA, Risau W 1992 Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359:845-848
8. Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, Comoglio PM 2003 Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3:347-361
9. Corpechot C, Barbu V, Wendum D, Chignard N, Housset C, Poupon R, Rosmordue O 2002 Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosis. Am J Pathol 160:613-620
10. Fukuoka H, Aoyama M, Miyazawa K, Asai K, Goto S 2005 Hypoxic stress enhances osteoclast differentiation via increasing IGF-2 production by non-osteoclastic cells. Biochem Biophys Res Commun 328:885-894
11. Augustin HG 2003 Translating angiogenesis research into the clinic: the challenges ahead. Br J Radiol 76:S3-S10
12. Shimizu K, Oku N 2004 Cancer anti-angiogenic therapy. Biol Pharm Bull 27:599-605
13. Purow B, Fine HA 2004 Progress report on the potential of angiogenesis inhibitors for neuro-oncology. Cancer Invest 22:577-587
14. von Schweinitz D, Hecker H, Harms D, Bode U, Weinel P, Burger D, Erttmann R, Mildenberger H 1995 Complete resection before development of drug resistance is essential for survival form advanced hepatoblastoma - a report from the German cooperative pediatric liver tumor study HB-89. J Pediatr Surg 30:845-852
15. Boehm T, Folkman J, Browder T, O'Reilly MS 1997 Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390:404-407
16. McCrudden KW, Hopkins B, Frischer J, Novikov A, Huang J, Kadenhe A, New T, Yokoi A, Yamashiro DJ, Kandell JJ, Middlesworth W 2003 Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis. J Pediatr Surg 38:308-314
17. Matsusaka S, Nakasjo K, Terada N, Sugihara A, Tsujimura T, Takanashi T, Uematsu K, Okamoto E, Toyosaka A 2000 Inhibition by an angiogenesis inhibitor, TNP-470, of the growth of a human hepatoblastoma heterotransplanted into nude mice. J Pediatr Surg 35:1198-1204
18. Bouck N, Stellmach V, Hsu SC 1996 How tumors become angiogenic. Adv Cancer Res 69:135-174
19. Hanahan D, Folkman J 1996 Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364
20. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP 1999 Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285:245-248
21. Tombran-Tink J, Mazuruk K, Rodriguez IR, Chung D, Linker T, Englander E, Chader GJ 1996 Organization, evolutionary conversation, expression and unusual Alu density of the human gene for pigment epithelium-derived factor, a unique neurotrophic serpin. Mol Vis 2:11-
22. Sawant S, Aparicio S, Tink AR, Lara N, Barnstable CJ, Tombran-Tink J 2004 Regulation o factors controlling angiogenesis in liver development: a role for PEDF in the formation and maintenance of normal vasculature. Biochem Biophys Res Commun 325:408-413
23. Doll JA, Stellmach VM, Bouck NP, Berg AR, Lee C, Abramson LP, Cornwell ML, Pins MR, Borensztajn J, Crawford SE 2003 Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas. Nat Med 9:774-780
24. Doll JA, Reiher FK, Crawford SE, Pins MR, Campbell SC, Bouck NP 2001 Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate. Prostate 49:293-305
25. Lee EJ, Anderson LM, Thimmapaya B, Jameson JL 1999 Targeted expression of toxic genes directed by pituitary hormone promoters: a potential strategy for adenovirus-mediated gene therapy of pituitary tumors. J Clin Endocrinol Metab 84:786-794
26. INK4a results in pancreatic cancer regression in vitro and in vivo. Gene Ther 8:199-208
27. Folkman J 1990 What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4-6
28. Tombran-Tink J, Barnstable CJ 2003 PEDF: multifaceted neurotrophic factor. Nat Rev Neurosci 4:628-636
29. Chader GJ 2001 PEDF: raising both hopes and questions in controlling angiogenesis. Proc Natl Acad Sci U S A 98:2122-2124
30. Abramson LP, Stellmach V, Doll JA, Cornwell M, Arensman RM, Crawford SE 2003 Wilms' tumor growth is suppressed by anti-angiogenic pigment epithelium-derived factor in xenograft model. J Pediatr Surg 38:336-342
31. Crawford SE, Stellmach V, Ranalli M, Huang X, Huang L, Volpert O, De Vries GH, Abramson LP, Bouck N 2001 Pigment epithelium-derived factor (PEDF) in neuroblastoma: a multifunctional mediator of Schwann cell antitumor activity. J Cell Sci 114:4421-4428
32. Streck CJ, Zhang Y, Zhou J, Ng C, Nathwani AC, Davidoff AM 2005 Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth. J Pediatr Surg 40:236-243
33. Matsumoto K, Ishikawa H, Nishimura D, Hamasaki K, Nakao K, Eguchi K 2004 Antiangiogenic property of pigment epithelium-derived factor in hepatocellular carcinoma. Hepatology 40:252-259
34. Stellmach V, Crawford SE, Zhou W, Bouck N 2001 Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor. Proc Natl Acad Sci U S A 98:2593-2597
35. Mahtabifard A, Merritt RE, Yamada RE, Crystal RG, Korst RJ 2003 In vivo gene transfer of pigment epithelium-derived factor inhibits tumor growth in syngeneic murine models of thoracic malignancies. J Thorac Cardiovasc Surg 126:28-38
36. Duh EJ, Yang HS, Suzuma I, Miyagi M, Youngman E, Mori K, Katai M, Yan L, Suzuma K, West K, Davarya S, Tong P, Gehlbach P, Pearlman J, Crabb JW, Aiello LP, Campochiaro PA, Zack DJ 2002 Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Invest Ophthamol Vis Sci 43:821-829
37. Garcia M, Fernandez-Garcia NI, Rivas V, Carretero M, Escamez MJ, Gonzalez-Martin A, Medrano EE, Volpert O, Jorcano JL, Jimenz B, Larcher F, Del Rio M 2004 Inhibition of xenografted human melanoma growth and prevention of metastasis development by dual antiangiogenic/antitumor activities of pigment epithelium-derived factor. Cancer Res 64:5632-5642
38. Lau K, Bicknell R 1999 Antiangiogenic gene therapy. Gene Ther 6:1793-1795